Just reported
From GE HealthCare Technologies's results release of 28 octobre 2026; its quarterly report has since been filed.
Actual
5,51B $US
+7,2 % y/y
+4,1 % q/q
Guided
—
No guide given
Actual
1,36 $US
+39 % y/y
+9,7 % q/q
Guided
—
No guide given
Actual
805M $US
+23 % y/y
+8,9 % q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Les parts du chiffre d'affaires sont des estimations pour nine months ended September 30, 2026, pas des chiffres tirés d'un document officiel.
Computed tomography scanners
Scanners use X-rays to create cross-sectional and three-dimensional images that can help clinicians find problems such as tumors, blocked blood vessels, or fractures.
Magnetic resonance scanners
Scanners use magnetic fields to create detailed images of internal body structures, including the brain, heart, and muscles.
Ultrasound systems
Systems use sound waves to create images for diagnosis and monitoring, including during pregnancy, heart examinations, and procedures.
X-ray systems
Fixed, portable, and moving-image X-ray equipment helps clinicians examine bones, lungs, and other parts of the body.
Patient monitors and electrocardiogram devices
Devices measure and display signs such as heart rhythm, blood pressure, and oxygen levels so care teams can track patients.
Contrast agents and radiopharmaceuticals
These medicines are given before or during scans to make certain tissues or biological activity easier to see in images.
GE HealthCare makes scanners that create images of the body using X-rays, magnetic fields, or sound waves, along with equipment used to guide procedures and monitor patients. It also sells contrast agents and radioactive imaging drugs that help clinicians interpret scans, and provides equipment maintenance, software, and cloud services. Its software includes tools that use artificial intelligence (AI) to help with image analysis and clinical workflows.
Construit à partir des documents déposés par GE HealthCare Technologies Inc. auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.
83,05 $US+1,5 %clôture 13 nov.
Chiffres jusqu’au 30 septembre 2026, issus du 10-Q déposé le 28 octobre 2026
GE HealthCare sells medical imaging scanners and ultrasound systems to hospitals and health systems, plus diagnostic imaging drugs.
The themes GE HealthCare Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Grade A
La bande sous le cours montre la note à chaque date, établie uniquement à partir des documents publics à ce moment-là.
Affichage de 2 trimestres sur 11 de l’historique des notes de GE HealthCare Technologies Inc.. Les 9 autres remontent jusqu’à février 2024.